0001214659-21-009372.txt : 20210909
0001214659-21-009372.hdr.sgml : 20210909
20210909173239
ACCESSION NUMBER: 0001214659-21-009372
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210909
FILED AS OF DATE: 20210909
DATE AS OF CHANGE: 20210909
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WITTE OWEN N.
CENTRAL INDEX KEY: 0001700969
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 211245289
MAIL ADDRESS:
STREET 1: C/O ALLOGENE THERAPEUTICS, INC.
STREET 2: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-53760.xml
PRIMARY DOCUMENT
X0306
4
2021-09-09
0001737287
Allogene Therapeutics, Inc.
ALLO
0001700969
WITTE OWEN N.
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
Common Stock
2021-09-09
4
S
false
5000
25.54
D
221182
D
/s/ Veer Bhavnagri, Attorney-in-Fact
2021-09-09